ADZE BIOTECHNOLOGY
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in the lab of Dr. Michael Barry of Mayo Clinic. The company was founded in 2019 and is based in Coral Gables, Florida.
ADZE BIOTECHNOLOGY
Industry:
Biotechnology Health Care Medical
Founded:
2019-01-01
Address:
Coral Gables, Florida, United States
Country:
United States
Website Url:
http://www.adzebiotech.com
Total Employee:
1+
Status:
Active
Contact:
+9177439401
Total Funding:
6.15 M USD
Similar Organizations
cCAM Biotherapeutics
cCAM Biotherapeutics is a pre-clinical stage company that develops immunotherapies for cancer.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Inspyr Therapeutics
Inspyr Therapeutics is a clinical stage company focused on novel targeted precision therapeutics for the treatment of cancer.
InnoRx
InnoRx is a development stage company, develops novel therapies for the ophthalmology market.
Red C Biotech
Red C Biotech is a pre-clinical, development stage company that aims to save lives by collaborating with organizations.
Saronic Biotechnology
Saronic Biotechnology, Inc. is committed to developing novel immunotherapies to cure liver cancer.
ViaMune
ViaMune is a preclinical-stage company with a mission to enable immunotherapy for patients with advanced cancers.
VISKA Bio
VISKA Bio is an early-stage immunotherapy platform that engages localized immunogenic cell death to treat and prevent cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.adzebiotech.com
- Host name: 6.9.214.35.bc.googleusercontent.com
- IP address: 35.214.9.6
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Adze Biotechnology"
About Adze Biotechnology | Cancer Immunotherapy
Adze Biotechnology is a pre-clinical stage company developing a portfolio of systemically deliverable oncolytic immunotherapies for the treatment of cancers.See details»
Adze Biotechnology | Oncolytic Immunotherapies for Cancer
Apr 8, 2024 Adze Biotechnology is developing a platform of immunotherapies that treat solid tumors and develop a robust anti-tumor immunity for patients.See details»
Adze Biotechnology - Crunchbase Company Profile
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers.See details»
Adze Biotechnology - Overview, News & Similar companies
View Adze Biotechnology (www.adzebiotech.com) location in Illinois, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Adze Biotechnology Inc: Contact Details and Business Profile
Adze Biotechnology Inc is a Biotechnology, Pharmaceuticals, and Healthcare company_reader located in Oak Park, Illinois with $1 million in revenue and 0 employees. Find top employees, …See details»
Adze Biotechnology - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Adze Biotechnology. Use the PitchBook Platform to explore the full profile.See details»
ADZE Biotechnology - Products, Competitors, Financials, …
ADZE Biotechnology focuses on the development of oncolytic immunotherapies within the biotechnology sector. Use the CB Insights Platform to explore ADZE Biotechnology's full profile.See details»
Adze Biotechnology - Org Chart, Teams, Culture & Jobs | The Org
View Adze Biotechnology's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Adze Biotechnology Completes $6.2 Million First …
Mar 16, 2023 “This first close of our Series A furthers our mission of bringing potentially life-saving treatments to patients in need.” – Sidney Hopps, Co-Founder & CEO CORAL GABLES, FLORIDA, US, March 16, 2023 Adze …See details»
Adze Biotechnology - Company Profile
Adze Biotechnology is a pre-clinical stage company that develops oncolytic immunotherapies for the treatment of cancers. It has exclusive licenses to oncolytic immunotherapies developed in …See details»
Adze Biotechnology Company Profile -Sales, Contacts, …
Business Description Adze Biotechnology is located in Miami, Florida. This organization primarily operates in the Drugs Affecting Neoplasms and Endrocrine Systems business / industry within …See details»
Adze Biotechnology - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Adze Biotechnology - Company Profile - Tracxn
Nov 1, 2024 Adzebiotech is developing targeted viruses that deliver immune-stimulatory and immune evasion blocking proteins to tumors. It provides self-amplifying oncolytic viruses target …See details»
Adze Biotechnology, Inc. - Drug pipelines, Patents, Clinical trials ...
About Center for Breakthrough Medicines (CBM) Center for Breakthrough Medicines (CBM) is a cell and gene therapy contract development and manufacturing organization (CDMO) uniquely …See details»
Partnering with Adze Biotechnology
We can partner in a different ways – partnerships by cancer indication, collaboration roles, and/or commercial territories. We invite you to connect with us at [email protected] to discuss …See details»
Adze Biotechnology Announces Orphan Drug Designation …
Feb 7, 2023 For more information, please visit Adzebiotech.com Investor & Media Contact: Sidney Hopps, CEO 917.743.9401 [email protected] Adze Biotechnology, Inc. 2332 …See details»
Adze Biotechnology Announces Orphan Drug Designation …
Feb 7, 2023 Adze-1.17-CD40L is a systemically deliverable, conditionally replicative oncolytic virus that delivers recombinent human CD40 ligand locally into solid tumors.See details»
Developing oncolytic immunotherapies | Adze Biotechnology …
Our scientists are developing oncolytic immunotherapies with the goal of treating solid tumors directly while making patients immune against their own cancer.See details»
Adze Biotechnology Pipeline
Despite recent advances in cancer therapeutics, severe unmet needs exist for patients world-wide, and many cancer patients still die each year. Adze oncolytic immunotherapies have the …See details»
News - Adze Biotechnology
Apr 8, 2024 “The Adze Scientific Advisory Board will provide important counsel in the years ahead, with research & development”, Sidney Hopps, Co-Founder & CEO Adze CORALLatest …See details»